Literature DB >> 22504705

Inhibition of tumor cell surface ATP synthesis by pigment epithelium-derived factor: implications for antitumor activity.

Monika Deshpande1, Luigi Notari, Preeti Subramanian, Vicente Notario, S Patricia Becerra.   

Abstract

Recently, we have shown that the antiangiogenic pigment epithelium-derived factor (PEDF) can bind the catalytic β-subunit of F1-ATP synthase and inhibit endothelial cell surface ATP synthase activity. This factor can additionally restrict tumor growth, invasion and metastasis, and can directly induce death on several tumor cell types. Active cell surface ATP synthase is also present in certain tumor cells and its ATP product is considered a stimulus for tumor growth. The present study aimed to elucidate the biological implications of the interactions between the extracellular PEDF and tumor cell surface ATP synthase. Incubation of T24 human urinary bladder carcinoma cells in media containing human recombinant PEDF protein for 48-96 h dramatically decreased cell viability in a concentration-dependent fashion as monitored by real-time cell impedance with a microelectronic system, microscopic imaging and biomarkers of live cells. Intact tumor cells exhibited cell surface ATP synthesis activity, which was inhibited by piceatannol, a specific inhibitor of F1/F0-ATP synthase. Immunoblotting revealed that the β subunit of F1-ATP synthase was present in plasma membrane fractions of these cells. Interestingly, pre-incubation of tumor cells with PEDF inhibited the activity of cell surface ATP synthase in a concentration-dependent fashion. The PEDF-derived peptide 34-mer decreased tumor cell viability and inhibited extracellular ATP synthesis to the same extent as full-length PEDF. Moreover, ATP additions attenuated both the PEDF-mediated decrease in tumor cell viability and the inhibition of endothelial cell tube formation. The results lead to conclude that PEDF is a novel inhibitor of tumor cell surface ATP synthase activity that exhibits a cytotoxic effect on tumor cells, and that the structural determinants for these properties are within the peptide region 34-mer of the PEDF polypeptide. The data strongly suggest a role for the interaction between the 34-mer region of PEDF and tumor cell-surface ATP synthase in promoting tumor cell death.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22504705      PMCID: PMC3546833          DOI: 10.3892/ijo.2012.1431

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  44 in total

Review 1.  Ecto-F₁-ATPase: a moonlighting protein complex and an unexpected apoA-I receptor.

Authors:  Pierre Vantourout; Claudia Radojkovic; Laeticia Lichtenstein; Véronique Pons; Eric Champagne; Laurent O Martinez
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

2.  Targeting cell surface F1F0 ATP synthase in cancer therapy.

Authors:  Yvonne M Mowery; Salvatore V Pizzo
Journal:  Cancer Biol Ther       Date:  2008-11-08       Impact factor: 4.742

3.  Identification of a novel inhibitor of the canonical Wnt pathway.

Authors:  Kyoungmin Park; Kyungwon Lee; Bin Zhang; Ti Zhou; Xi He; Guoquan Gao; Anne R Murray; Jian-Xing Ma
Journal:  Mol Cell Biol       Date:  2011-05-16       Impact factor: 4.272

4.  Binding of pigment epithelium-derived factor (PEDF) to retinoblastoma cells and cerebellar granule neurons. Evidence for a PEDF receptor.

Authors:  E Alberdi; M S Aymerich; S P Becerra
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

Review 5.  The neuroprotective role of PEDF: implication for the therapy of neurological disorders.

Authors:  T Yabe; T Sanagi; H Yamada
Journal:  Curr Mol Med       Date:  2010-04       Impact factor: 2.222

Review 6.  The role of PEDF in tumor growth and metastasis.

Authors:  D Hoshina; R Abe; S-I Yamagishi; H Shimizu
Journal:  Curr Mol Med       Date:  2010-04       Impact factor: 2.222

7.  Pigment epithelium-derived factor binds to cell-surface F(1)-ATP synthase.

Authors:  Luigi Notari; Naokatu Arakaki; David Mueller; Scott Meier; Juan Amaral; S P Becerra
Journal:  FEBS J       Date:  2010-05       Impact factor: 5.542

Review 8.  In vitro and in vivo biological activity of PEDF against a range of tumors.

Authors:  Matthew L Broadhead; Crispin R Dass; Peter F M Choong
Journal:  Expert Opin Ther Targets       Date:  2009-12       Impact factor: 6.902

9.  Laminin receptor involvement in the anti-angiogenic activity of pigment epithelium-derived factor.

Authors:  Adrien Bernard; Jacqueline Gao-Li; Claudio-Areias Franco; Tahar Bouceba; Alexis Huet; Zhenlin Li
Journal:  J Biol Chem       Date:  2009-02-17       Impact factor: 5.157

10.  A novel ligand in lymphocyte-mediated cytotoxicity: expression of the beta subunit of H+ transporting ATP synthase on the surface of tumor cell lines.

Authors:  B Das; M O Mondragon; M Sadeghian; V B Hatcher; A J Norin
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  14 in total

1.  Inhibition of retinal neovascularization by a PEDF-derived nonapeptide in newborn mice subjected to oxygen-induced ischemic retinopathy.

Authors:  Nader Sheibani; Ismail S Zaitoun; Shoujian Wang; Soesiawati R Darjatmoko; Andrew Suscha; Yong-Seok Song; Christine M Sorenson; Victor Shifrin; Daniel M Albert; Ignacio Melgar-Asensio; Irawati Kandela; Jack Henkin
Journal:  Exp Eye Res       Date:  2020-04-06       Impact factor: 3.467

2.  A humanized chimeric antibody Hai178 targeted to the β subunit of F1F0 ATP synthase.

Authors:  Chen Chen; Hui Liang; Xinmei Liao; Jian Pan; Jianhe Chen; Shibi Zhao; Yan Xu; Yun Wu; Jian Ni
Journal:  Tumour Biol       Date:  2016-10-04

3.  Recombinant pigment epithelium-derived factor PEDF binds vascular endothelial growth factor receptors 1 and 2.

Authors:  Erin K Johnston; Mary K Francis; Janice E Knepper
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-05-07       Impact factor: 2.416

Review 4.  Natural products and other inhibitors of F1FO ATP synthase.

Authors:  Bhargav A Patel; Terin L D'Amico; Brian S J Blagg
Journal:  Eur J Med Chem       Date:  2020-09-03       Impact factor: 6.514

5.  ATP release mechanisms of endothelial cell-mediated stimulus-dependent hyperalgesia.

Authors:  Elizabeth K Joseph; Paul G Green; Jon D Levine
Journal:  J Pain       Date:  2014-05-02       Impact factor: 5.820

Review 6.  The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential.

Authors:  S Patricia Becerra; Vicente Notario
Journal:  Nat Rev Cancer       Date:  2013-03-14       Impact factor: 60.716

7.  Pigment epithelium-derived factor (PEDF) prevents retinal cell death via PEDF Receptor (PEDF-R): identification of a functional ligand binding site.

Authors:  Preeti Subramanian; Silvia Locatelli-Hoops; Jason Kenealey; Jacqueline DesJardin; Luigi Notari; S Patricia Becerra
Journal:  J Biol Chem       Date:  2013-07-01       Impact factor: 5.157

8.  Temporal Phosphoproteome Dynamics Induced by an ATP Synthase Inhibitor Citreoviridin.

Authors:  Chia-Wei Hu; Chia-Lang Hsu; Yu-Chao Wang; Yasushi Ishihama; Wei-Chi Ku; Hsuan-Cheng Huang; Hsueh-Fen Juan
Journal:  Mol Cell Proteomics       Date:  2015-10-26       Impact factor: 5.911

Review 9.  Revisiting the matricellular concept.

Authors:  Joanne E Murphy-Ullrich; E Helene Sage
Journal:  Matrix Biol       Date:  2014-07-24       Impact factor: 11.583

10.  Small Retinoprotective Peptides Reveal a Receptor-binding Region on Pigment Epithelium-derived Factor.

Authors:  Jason Kenealey; Preeti Subramanian; Antonella Comitato; Jeanee Bullock; Laura Keehan; Federica Polato; David Hoover; Valeria Marigo; S Patricia Becerra
Journal:  J Biol Chem       Date:  2015-08-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.